The Malaria Challenge: A Global Overview

Before diving into the UAE’s remarkable achievement in eliminating malaria, it’s important to understand the global context. Malaria, caused by parasites of the Plasmodium genus—especially P. falciparum and P. vivax—is transmitted through the bite of infected mosquitoes. Despite decades of progress, malaria remains a pressing public health challenge, disproportionately affecting children under five and pregnant women.
According to the World Health Organization (WHO), in 2022 alone, there were an estimated 249 million malaria cases and 608,000 related deaths across 85 malaria-endemic regions, the majority in sub-Saharan Africa. The disease is not only a health burden but also an economic one, reducing productivity and increasing healthcare costs in affected countries.

The UAE’s Ambitious Mission to Eliminate Malaria

The UAE’s journey toward malaria elimination began in the 1950s, during a period of rapid development and limited healthcare infrastructure. At the time, malaria prevalence ranged between 30% and 60%, affecting both rural and urban populations. The disease posed a significant threat to public health and development. Initial control efforts in the 1970s were sporadic and lacked coordination, which led to recurring outbreaks, including a major one between 1975 and 1977.
Faced with these challenges, the UAE government took decisive action and established a Central Malaria Control Department in 1979. Based in Sharjah, this department introduced a comprehensive, nationwide strategy encompassing early case detection, prompt treatment, vector control, and coordinated efforts with the Ministry of Agriculture and local municipalities. Training, capacity building, and operational research also became integral components of the program, ensuring long-term sustainability and adaptability.
The results were swift and striking: malaria cases dropped from 22,791 in 1978 to 11,599 in 1979. By 1980, disease transmission was largely interrupted, with incidence rates falling to 8 cases per 1,000 population. The last locally transmitted case was recorded in Masfout in July 1997, marking a historic milestone in the country’s fight against malaria.

What Worked: Key Strategies Behind the UAE’s Success

  1. Surveillance and Early Detection
    A cornerstone of the UAE’s approach was the establishment of a robust surveillance system. This enabled health authorities to detect and treat malaria cases swiftly, minimizing the risk of further transmission. Active case detection was supported by advanced diagnostic tools, including microscopy and rapid diagnostic tests (RDTs), which were introduced across healthcare facilities—even in remote areas.
  2. Vector Control
    The country invested significantly in vector control programs. This included large-scale insecticide spraying campaigns, larval source management, and environmental engineering to eliminate mosquito breeding sites. The integration of environmental strategies—such as proper drainage systems and water management, played a vital role in long-term mosquito control.
  3. Universal Access to Treatment
    One of the UAE’s most effective tools in its fight against malaria was the provision of universal healthcare. Citizens and residents had free access to medical services, ensuring that suspected malaria cases could receive timely diagnosis and treatment. The use of effective antimalarial drugs further helped reduce the duration of illness and prevent complications.
  4. Public Awareness and Education
    Nationwide public education campaigns were conducted to increase awareness of malaria prevention methods. These campaigns emphasized the use of insecticide-treated nets, wearing protective clothing, and avoiding outdoor exposure during peak mosquito hours. Community engagement was a key in reaching the ultimate goal of eradication.
  5. International Collaboration
    Partnerships with global organizations, like the WHO, were instrumental in the UAE’s success. These collaborations provided technical expertise, resources, and access to global best practices. The UAE also contributed to regional knowledge sharing, helping other countries strengthen their malaria control strategies.

Recognition and Vigilance: Sustaining a Malaria-Free Status

In 2007, the WHO officially declared the UAE malaria-free, making it one of the first countries in the Middle East to earn this recognition. This declaration reflected not only the elimination of local transmission but also the country’s capacity to prevent future outbreaks.
However, with globalization and increased international mobility, the threat of imported cases remains. As a major hub for tourism, trade, and labor migration, the UAE is exposed to potential reintroductions of the disease. To address this, the country has implemented vigilant screening protocols, continuous monitoring of imported cases, and rapid response systems to contain any outbreaks.

Ongoing risk assessments consider two critical factors:
– Receptivity: The ecological and environmental conditions in the UAE that could support the life cycle of malaria vectors.
– Vulnerability: The likelihood of the malaria parasite being reintroduced through infected travelers or migrant populations.

Conclusion: A Blueprint for Global Malaria Elimination

The UAE’s experience proves that malaria elimination is not only achievable but also sustainable with the right mix of political commitment, integrated strategies, and active community participation.

Its story stands as a beacon of hope and a practical model for other nations striving to eliminate this preventable disease. Scribble-04

As the global health community intensifies efforts to combat malaria, the UAE’s journey serves as a powerful reminder of what is possible when a country invests in people, science, and collaboration. Through sustained vigilance and international cooperation, we move closer to a world where malaria is not just controlled, but eradicated.

 Dr Nada Al Marzooqi, Director of Public Health and Prevention, Department Public Health and Prevention

Dr Nada Al Marzooqi, Director of Public Health and Prevention, Department Public Health and Prevention

• Nada Al-Marzooqi obtained her MD degree from Sultan Qaboos University (Sultanate of Oman) and a MPH from JHSPH (Baltimore, USA). She is certified in Arab Board for Medical Specialization in Community Medicine.
• She has been developed her leadership skills through several leadership programs such as: UAE Government Leadership Program – “Executive Leaders” 2017; World Health Organization (WHO): “The Leadership for Health Programme” 2015; American University of Beirut (AUB) “Leadership in Healthcare Program Diploma” 2010; INSEAD: “Middle East Health Leadership Programme” 2009.
• She was honored by HH Sh Mohamed Bin Rashid Al –Maktoum as the first UAE officers who were trained for The National Program for Happiness and Positivity in 2017
• She has worked in several positions in the Ministry of Health and Prevention in UAE and was the Director of the Preventive Medicine Department from 2015-March 2022 where a new organization reform has been implemented.
• She has been the first Chief Happiness and Positivity Officer in MOHAP, leading initiatives to increase the happiness environment in workplace.
• She is currently the Director for the Public Health and Prevention Department in the Ministry of Health and Prevention in UAE, overlooking communicable and non-communicable diseases prevention programs, national Immunization Program, Family Health and Environmental Health.
• In COVID-19 Pandemic, she is managing the public health interventions in the ministry and serves as the deputy in the National Technical Pandemic Team and head the National COVID Vaccination team.
• Her major expertise is in Public Health and she has a special interest in CD and NCD programs and developing surveillance systems, unified national polices and legislations, along with establishing monitoring and prevention programs. She is part of the national committees for pandemic preparedness and communicable diseases technical groups in in UAE. She regularly serves as a technical adviser for the MOHAP in relation to surveillance, HIV prevention and control, communicable diseases control, immunization, Diabetes and Cancer registries and research, as well as, evaluation of CD and NCD programs and policies.